'Protein microarrays' may reveal new weapons against malaria

November 1, 2011, Walter and Eliza Hall Institute
Dr. Alyssa Barry from the infection and immunity division is using "protein microarray" technology to screen human blood serum samples for immunity to malaria. Credit: The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.

A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.

Dr Alyssa Barry from the Walter and Eliza Hall Institute's Infection and Immunity division is using 'protein microarray' technology to screen human samples for immunity to proteins produced by the malaria-causing Plasmodium falciparum parasite. Her research, which determines a person's immunity to hundreds of proteins simultaneously, has been published in the journal Molecular and Cellular Proteomics this month.

Malaria is a mosquito-borne disease that affects more than 500 million people each year. It causes more than one million deaths, mostly in children under five years of age.

Dr Barry is investigating how humans living in countries where malaria is prevalent, such as Papua New Guinea, establish immunity that protects them from developing malaria.

The has evolved many ways to evade the immune system, Dr Barry said. "We know that one , called PfEMP1, that is particularly important for the host can be produced in many different varieties, and these can be altered by the parasite to avoid detection by the immune system."

Dr Barry and colleagues at the Queensland Institute of Medical Research, the Papua New Guinea Institute of Medical Research and the University of California Irvine adapted existing protein microarray technology to allow small samples of human serum (less than one hundredth of a millilitre) to be tested simultaneously against hundreds of variants of PfEMP1 to determine to which variants the person was immune.

Dr Barry said the testing revealed that in a small region of Papua New Guinea where malaria is endemic, children under the age of two are immune to only a few specific variants of PfEMP1 while older children and adults show immunity to an increasing range of PfEMP1 variants.

"Young children are the most vulnerable to malaria," she said. "Our studies show that this is partly because they have not developed immunity to the many different malaria variants to which they are exposed. As people get older, they become immune to a wider spectrum of malaria parasites, and so when they are infected they develop milder disease and eventually do not develop disease at all, although they can still be infected."

The research team is now undertaking a larger study that will screen more people from other regions of , and will screen a wider variety of Plasmodium protein variants.

Dr Barry said she hoped the research would lead to the development of a diagnostic test for susceptibility to malaria, and also determine which proteins might be the best to use as the basis for a malaria vaccine. "We currently do not know how people become to malaria," she said. "Our protein microarray technology could assist in monitoring control and elimination programs, by showing when a population becomes more susceptible to the disease as a result of waning immunity."

Explore further: Multiple malaria vaccine offers protection to people most at risk

Related Stories

Multiple malaria vaccine offers protection to people most at risk

October 26, 2011
A new malaria vaccine could be the first to tackle different forms of the disease and help those most vulnerable to infection, a study suggests.

Malaria parasites camouflage themselves from the immune defenses of expectant mothers

August 19, 2011
Collaborative research between Liverpool School of Tropical Medicine and the University of Copenhagen, published last week in the Proceedings of the National Academy of Sciences, have answered a long standing mystery, why ...

Recommended for you

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

Obese fat becomes inflamed and scarred, which may make weight loss harder

January 12, 2018
The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.

Optimized human peptide found to be an effective antibacterial agent

January 11, 2018
A team of researchers in the Netherlands has developed an effective antibacterial ointment based on an optimized human peptide. In their paper published in the journal Science Translational Medicine, the group describes developing ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

hush1
not rated yet Nov 01, 2011
During which you can encourage the genetic mutation for asymmetrical wing span of all mosquitoes resulting in circular flight. The carry over to other species is without consequence.
No eradication. No extinction. No natural selection pressure.
All species have predictable flight and location.

Buys time and saves lives until you finish your work.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.